Boston Scientific (BSX) Net Margin (2009 - 2026)

Boston Scientific has disclosed Net Margin across 18 years of filings, most recently posting 25.77% for Q1 2026.

• Net Margin for Q1 2026 came in at 25.77%, up 1132.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 17.29% (up 572.0% YoY), and the FY2025 annual result was 14.44%, up 337.0% from the prior year.
• Net Margin came in at 25.77% for Q1 2026 at Boston Scientific, up from 12.71% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 25.77% in Q1 2026 to a low of 3.21% in Q1 2022.
• The 5-year median for Net Margin is 12.39% (2024), against an average of 11.29%.
• Across the five-year window, Net Margin sank 868 bps in 2022 and jumped 1132 bps in 2026, its largest moves.
• Boston Scientific's Net Margin stood at 3.89% in 2022, then jumped by 249 bps to 13.56% in 2023, then retreated by 9 bps to 12.39% in 2024, then gained by 3 bps to 12.71% in 2025, then soared by 103 bps to 25.77% in 2026.
• The last three Net Margin figures came in at 25.77% (Q1 2026), 12.71% (Q4 2025), and 14.91% (Q3 2025), per Business Quant data.